Market Commentary: 3 Breakouts Signal Santa Claus Rally
Barely a couple of weeks ago, the tenor of the markets changed. Cathie Wood, the poster girl for high growth stocks, reported massive gains among her portfolio of stocks.
In a single week, Nurix Therapeutics gained 16%, Pinterest rose by 19%, Verve Therapeutics flew higher by 18%, Ceres was up 15%, Shopify soared by 22% and Palantir was up 20%. » Read more about: Market Commentary: 3 Breakouts Signal Santa Claus Rally »
Read More1 Pet Stock You’d Be Barking Mad Not to Buy
Pet insurance is big business and Trupanion is a popular insurance company for pet lovers. Over 1.1 million pets were enrolled in Trupanion at last count, up 37% year over year.
The pet insurer makes for an intriguing investment opportunity: a business model that has product-market fit, lots of room to grow, and a proven history of customer satisfaction.
» Read more about: 1 Pet Stock You’d Be Barking Mad Not to Buy »
Read MoreForget Sports, Buy Sports Data Stocks
Like everything else data-related in the 21st century, sports analytics has exploded in recent years. In 2020, the sports analytics market was valued at USD 885 million. Analysts are forecasting the sports analytics space will continue to grow at a compound yearly rate of 21.3 percent from 2021 to 2028.
Sports analytics is part of a larger sports technology market,
» Read more about: Forget Sports, Buy Sports Data Stocks »
Read MoreSolana Price Predictions – Is It Worth Buying?
Over the last couple of months, the Cryptocurrency bull run has stalled and turned into a bear market with prices down over 20% from their highs. However, with the recent explosion in crypto creation, development and launches, it can be overwhelming to decide which coin or project you should be investing in.
While Bitcoin and Ethereum grab most of the headlines,
» Read more about: Solana Price Predictions – Is It Worth Buying? »
Read MoreMarket Commentary: Is It Time To Buy Bitcoin?
It seems that Grayscale’s spot Bitcoin ETF has been in regulatory limbo longer than a Siberian Winter due to the Securities and Exchange Commission’s (SEC) hesitance to green-light it and that’s translating to frenetic moves in crypto once again.
In a recent decision, the SEC was ordered by a U.S. appeals court to review Grayscale’s application for a spot Bitcoin ETF.
» Read more about: Market Commentary: Is It Time To Buy Bitcoin? »
Read MoreThe Ivy
1 Tool That Forecasts Recession Has Perfect Record
Oh gee, not only do bulls have to worry about how the CAPE index has risen above 30, historically a signal of an impending market correction. And not only do they have to be skittish about Nvidia hitting a $2 trillion market capitalization, leaving Meta and other Magnificent 7 stocks in the dust on valuation,
» Read more about: 1 Tool That Forecasts Recession Has Perfect Record »
Read MoreThe Spotlight
Is This Healthcare Stock The NEXT BIG THING?
Doximity is a cloud-based platform that helps medical professionals connect and collaborate with their colleagues. It has been compared to LinkedIn for doctors by allowing them to search for new job opportunities, keep up with the latest medical research, and communicate with other physicians in a more efficient way.
The company has an estimated 80% of US doctors on the platform in addition to a large number of top pharmaceutical companies and hospitals in the US,
» Read more about: Is This Healthcare Stock The NEXT BIG THING? »
Read More